Table 1 Demographics of participants enrolled in the booster dose study.

From: Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants

 

Booster (N = 91)

Non-booster (N = 93)

Age, years

Median

35.0 (25.0–44.0)

36.0 (26.0–44.0)

 ≥ 12 to < 18

0 (0%)

4 (4.3%)

 ≥ 18 to < 55

85 (93.4%)

82 (88.2%)

 ≥ 55 to ≤ 65

6 (6.6%)

7 (7.5%)

Sex

Female

24 (26.4%)

20 (21.5%)

Male

67 (73.6%)

73 (78.5%)

Body Mass Index, kg/m2

25.3 (3.5)

24.7 (2.7)

  1. Data represents median (IQR), n (%) or mean (SD).
Back to article page